Immune-evading cells with PD-L1 control diabetes in mice
Generating insulin-producing pancreatic beta cells from stem cells to replace those that have been destroyed by the immune system is a promising approach to treating diabetes. But it has proven challenging to make the cells responsive to glucose changes and to prevent an immune attack after the cells are transplanted.